Showing results (411-420 of 2,126) with videos related to
Sort By:
Pageof 213
Helicobacter|September 6, 2019
Review: Treatment of Helicobacter pylori Infection 2019Anthony O'Connor, Jyh-Ming Liou, Javier P Gisbert, et al.Helicobacter|September 6, 2019
Review: Helicobacter: Inflammation, immunology, and vaccinesPhilippe Lehours, Richard L FerreroHelicobacter|September 6, 2019
Review: Helicobacter pylori in pediatricsZrinjka Mišak, Iva Hojsak, Matjaž HomanHelicobacter|October 28, 2016
Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birthWouter J den Hollander, Sarah Schalekamp-Timmermans, I Lisanne Holster, et al.Helicobacter|February 20, 2019
Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trialBingyun Lu, Jiamin Wang, Jing Li, et al.Helicobacter|February 19, 2019
Gastric cancer prevention targeted on risk assessment: Gastritis OLGA stagingMassimo Rugge, Kentaro Sugano, Carmelo Scarpignato, et al.Helicobacter|March 9, 2019
Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled studyTongyu Wang, Xiaoxiao Yang, Yueyue Li, et al.Helicobacter|March 1, 2017
The histone-like protein HU has a role in gene expression during the acid adaptation response in Helicobacter pyloriAlhejandra Álvarez, Héctor ToledoHelicobacter|December 29, 2016
A novel isolation protocol and probe-based RT-PCR for diagnosis of gastric infections with the zoonotic pathogen Helicobacter suisCaroline Blaecher, Eva Bauwens, Alfred Tay, et al.Helicobacter|March 13, 2019
Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapyAzucena Arévalo Galvis, Alba Alicia Trespalacios Rangel, William Otero ReginoPageof 213